LSBCF (LakeShore Biopharma Co) Other Long Term Assets: $5.28 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is LakeShore Biopharma Co Other Long Term Assets?

LakeShore Biopharma Co LSBCF Other Long Term Assets is $5.28 Mil as of Mar. 2025.

LakeShore Biopharma Co's other long-term assets for the quarter that ended in Mar. 2025 was $5.28 Mil.

LakeShore Biopharma Co's quarterly other long-term assets increased from Mar. 2024 ($8.05 Mil) to Sep. 2024 ($8.79 Mil) but then stayed the same from Sep. 2024 ($8.79 Mil) to Mar. 2025 ($5.28 Mil).

LakeShore Biopharma Co's annual other long-term assets increased from Mar. 2023 ($3.31 Mil) to Mar. 2024 ($8.05 Mil) but then declined from Mar. 2024 ($8.05 Mil) to Mar. 2025 ($5.28 Mil).

LakeShore Biopharma Co Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Other Long Term Assets Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Other Long Term Assets
14.86 4.93 3.31 8.05 5.28

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only 3.31 4.21 8.05 8.79 5.28

LakeShore Biopharma Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of $5.28 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Other Long Term Assets of $5.28 Mil as of Mar. 2025. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Other Long Term Assets too high?
LakeShore Biopharma Co's current Other Long Term Assets is $5.28 Mil.
How does LakeShore Biopharma Co's Other Long Term Assets compare to ACUT and PPCB?
LakeShore Biopharma Co's Other Long Term Assets of $5.28 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Biotechnology company?
A good Other Long Term Assets depends on the Biotechnology industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Other Long Term Assets is $5.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Other Long Term Assets of $5.28 Mil. The current Other Long Term Assets is $5.28 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Other Long Term Assets is $5.28 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.